IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis.

Yao, Lichao; Hu, Xue; Yuan, Mengqin; Zhang, Qiuling; Liu, Pingji; Yang, Lian; Dai, Kai; Jiang, Yingan

Yao, Lichao; Hu, Xue; Yuan, Mengqin; Zhang, Qiuling; Liu, Pingji; Yang, Lian; Dai, Kai; Jiang, Yingan.

Afiliação

Yao L; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Hu X; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Yuan M; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Zhang Q; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Liu P; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Yang L; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Dai K; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Jiang Y; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

J Clin Transl Hepatol ; 11(4): 787-799, 2023 Aug 28.

Article em En | MEDLINE | ID: mdl-37408817

Palavras-chave

Cell therapy; Hepatic stellate cell; IGF2; Liver cirrhosis; Macrophage

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Transl Hepatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google